As Australian clinicians begin to deliver MDMA and psilocybin-assisted therapies, they will require guidance from experienced practitioners with years of experience working with these therapies. To support this, MMA is providing ongoing professional mentoring for graduates of our leading CPAT course, led by members of its international faculty.
Mentoring sessions run as follows:
- Delivery: online via Zoom
- Duration: 75 minutes
- Group Size: 5 people max. per session
- Cost: $100 per session
If you’ve graduated from our CPAT course and you would like to be involved, please email email@example.com.
Please note that mentoring is only available for graduates of our CPAT course.
A member of our team will reach out to provide further details.
Dr William (Bill) Richards (USA)
William A. Richards (Bill) is the Director of Therapy at Sunstone Therapies and a psychologist in the Center for Psychedelic and Consciousness Research at the Johns Hopkins School of Medicine. He has been implementing research studies with psilocybin since 1999. His graduate degrees include M.Div. (Yale) , S.T.M. (Andover-Newton) and Ph.D. (Catholic University). He also studied with Abraham Maslow at Brandeis University and with Hanscarl Leuner at Georg-August University in Göttingen, Germany, where his involvement with psilocybin research originated in 1963. From 1967 to 1977, he implemented projects of psychotherapy research with LSD, DPT, MDA and psilocybin at the Maryland Psychiatric Research Center, including protocols designed to investigate the promise of psychedelics in the treatment of alcoholism, depression, narcotic addiction and the psychological distress associated with terminal cancer, and also their use in the training of religious and mental-health professionals. His book, Sacred Knowledge: Psychedelics and Religious Experiences has been released by Columbia University Press.
Dr Lauren Macdonald (UK)
BMBS, BSc, PGCert
Dr Lauren Macdonald is a psychiatry doctor and therapy guide at the Centre for Psychedelic Research, Imperial College London. She currently works on trials studying psilocybin-assisted therapy for anorexia nervosa and fibromyalgia, and DMT for treatment-resistant depression. Alongside her clinical work she is a retreat facilitator and co-founder at Essence Medicine, an organisation providing psycho-spiritual care to people facing life threatening illness. She has degrees in Medicine and Psychology, and has undertaken further training in Integrative Medicine, Compassionate Inquiry, Yoga, and Psychedelic-Assisted Therapy (Multidisciplinary Association for Psychedelic Studies).
Sara Reed (USA)
Sara Reed is a Licensed Marriage and Family Therapist and psychedelic research therapist at Imperial College London. Her prior research work includes participation as a study therapist for a Phase 2 MDMA clinical study of Posttraumatic Stress Disorder (PTSD) sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). She additionally received training at Yale University for the Psilocybin-Induced Neuroplasticity in the Treatment of Major Depressive Disorder study and is listed as a contributor to the therapist training manual for this treatment. Sara has spent her early career examining ways culture informs how we diagnose and treat mental illness. As a mental health futurist, she reimagines what mental wellness can look like in this digital era. Sara lectures on topics fusing culturally sensitive practices within mental health care and advises organizations on anti-oppressive and inclusive practices.
Dr Brian Richards (USA)
Brian D. Richards, Psy.D., completed a Master’s degree in Existential-Phenomenological Psychology at Duquesne University, a Psy.D. at the University of Denver School for Professional Psychology, and a Postdoctoral Fellowship at the Johns Hopkins Behavioral Pharmacology Research Unit (now the Center for Psychedelic and Consciousness Research), where he contributed to some of the original research administering psilocybin with cancer patients and healthy normal adults. Dr. Richards was formerly a Clinical Director with MedOptions, the largest behavioral health provider in the United States. He now cares for patients with a cancer diagnosis at Maryland Oncology Hematology, The Aquilino Cancer Center, and works with Sunstone Therapies on clinical trials with LSD, psilocybin, and MDMA. Dr. Richards also teaches and mentors students at the California Institute for Integral Studies, the leading Psychedelic Medicine Certificate Program worldwide. He is a Subject Matter Expert on Psilocybin with the Board of Psychedelic Medicine and Therapies, and has worked with BrainFutures on Coding and Reimbursement for Psychedelic-Assisted Therapy.